| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_NFATC3_0002300 | Intron-Exon | chr16:68132225-68225678 | chr16:68098322-68191775 | 250 nt | 0.4080 |
| hsa_NFATC3_0002700 | Intron-Exon-Intron | chr16:68137898-68160513 | chr16:68103995-68126610 | 101 nt | 0.3861 |
| hsa_NFATC3_0003300 | Intron-Exon-Intron | chr16:68150917-68160513 | chr16:68117014-68126610 | 280 nt | 0.4107 |
| hsa_NFATC3_0003400 | Intron-Exon-Intron | chr16:68150917-68191971 | chr16:68117014-68158068 | 117 nt | 0.3590 |
| hsa_NFATC3_0003500 | Intron-Exon-Intron | chr16:68150917-68208417 | chr16:68117014-68174514 | 290 nt | 0.3931 |
| hsa_NFATC3_0003600 | Intron-Exon-Intron | chr16:68150917-68217269 | chr16:68117014-68183366 | 189 nt | 0.4497 |
| hsa_NFATC3_0003100 | Intron-Exon-Intron | chr16:68150917-68248335 | chr16:68117014-68214432 | 250 nt | 0.3280 |
| hsa_NFATC3_0003200 | Intron-Exon | chr16:68150917-68260462 | chr16:68117014-68226559 | 250 nt | 0.3480 |
| hsa_NFATC3_0003800 | Intron-Exon-Intron | chr16:68150936-68160513 | chr16:68117033-68126610 | 261 nt | 0.4138 |
| hsa_NFATC3_0003900 | Intron-Exon-Intron | chr16:68150936-68217269 | chr16:68117033-68183366 | 183 nt | 0.4481 |
A study in human peripheral whole blood samples selected the circNFATC3 for validation but eliminated it from the final age prediction model due to barely detectable expression (Ct >37) in RT-qPCR assays [Wang et al. DOI:10.3389/fgene.2022.1031806].